• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION IMUFLEX BLOOD BAG SYSTEM; IMUFLEX WB-SP BLOOD BAG SYSTEM WITH LR FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION IMUFLEX BLOOD BAG SYSTEM; IMUFLEX WB-SP BLOOD BAG SYSTEM WITH LR FILTER Back to Search Results
Catalog Number 1BBLGQ506A6
Device Problems Defective Component (2292); High Test Results (2457)
Patient Problem No Patient Involvement (2645)
Event Date 06/12/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Investigation is in process.A follow up report will be provided.
 
Event Description
The customer reported elevated white blood cell (wbc) content in a filtered whole blood unit.There was not a transfusion recipient or patient involved at the time of whole blood processing, therefore no patient information is reasonably known at the time of the event.Donor unit #: (b)(4).
 
Manufacturer Narrative
This report is being filed to provide additional information: investigation: one set of blood bags with the filter from the collection set were returnedfor evaluation.The white clamp above the filter was closed and 570ml of water was injected into thedonation bag to check if water would pass though the one-way valve line the bypass linethrough natural dropping.It was confirmed that the water did not flow pass the one-way valveand air did not pass through the lower side from the upper side.It was confirmed that theone-way valve was normal.The leukoreduction filter was tested for flow rate and air leaks.A slow flow rate of 12.5 ml/inwas noted and it was confirmed the filter was connected in the correct direction and noanomalies were observed in the line.The manufacturing records, test records, and inspection records were reviewed forabnormalities and none were found.There were no equipment issues at the time ofmanufacture that would have contributed to the reported event.It was confirmed that there were no similar complaints from other medical institutions for thereported event as of 07/06/2018.The records regarding the particulate removal rates of the filter membranes were reviewed.Allmembranes conformed to established specification.Root cause: a definitive root cause for the observed elevated wbc count remainsundetermined at this time.The returned sample was almost entirely dyed darker with toluidineblue, therefore, it is possible that occlusion occurred in the second filter membrane andsubsequent filter membranes.Hence, blood may have been filtered by a smaller than usual filterarea and the linear speed increased and resulted in leukocyte contamination.For this event, the extension of filtration time is likely to occur concurrently.For previouslyreported similar events, the clogged components were inferred to be aggregate platelets.It ispossible that the platelets which were activated and aggregated were trapped by the filter.Asa result, a clogged filter may have occurred and interrupted blood flow.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMUFLEX BLOOD BAG SYSTEM
Type of Device
IMUFLEX WB-SP BLOOD BAG SYSTEM WITH LR FILTER
Manufacturer (Section D)
TERUMO CORPORATION
fujinomiya
MDR Report Key7666002
MDR Text Key113642364
Report Number9681839-2018-00045
Device Sequence Number1
Product Code CAK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 07/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2018
Device Catalogue Number1BBLGQ506A6
Device Lot Number170630AF
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/18/2018
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date06/13/2018
Device Age13 MO
Event Location Hospital
Date Report to Manufacturer07/06/2018
Initial Date Manufacturer Received 06/13/2018
Initial Date FDA Received07/06/2018
Supplement Dates Manufacturer Received07/10/2018
Supplement Dates FDA Received07/31/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-